These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 19627038

  • 1. [Persistent low levels of human chorionic gonadotropin in the serum: investigation and management].
    Faranesh R, Ben-David Y.
    Harefuah; 2009 Feb; 148(2):101-3, 139. PubMed ID: 19627038
    [Abstract] [Full Text] [Related]

  • 2. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA, Khanlian SA, Giddings A, Butler SA, Muller CY, Hammond C, Kohorn E.
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [Abstract] [Full Text] [Related]

  • 3. Inappropriate management of women with persistent low hCG results.
    Cole LA, Khanlian SA.
    J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
    [Abstract] [Full Text] [Related]

  • 4. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
    Khanlian SA, Cole LA.
    J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
    [Abstract] [Full Text] [Related]

  • 5. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA, Butler SA, Khanlian SA, Giddings A, Muller CY, Seckl MJ, Kohorn EI.
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [Abstract] [Full Text] [Related]

  • 6. What we know about low-level hCG: definition, classification and management.
    Kohorn EI.
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [Abstract] [Full Text] [Related]

  • 7. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA, Butler S.
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [Abstract] [Full Text] [Related]

  • 8. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI.
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [Abstract] [Full Text] [Related]

  • 9. Phantom hCG and phantom choriocarcinoma.
    Cole LA.
    Gynecol Oncol; 1998 Nov; 71(2):325-9. PubMed ID: 9826481
    [Abstract] [Full Text] [Related]

  • 10. Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report.
    Sasaki S, Sasaki Y, Iino K.
    J Reprod Med; 2010 Nov; 55(7-8):317-20. PubMed ID: 20795345
    [Abstract] [Full Text] [Related]

  • 11. A rapid solid-phase radioimmunoassay specific for human chorionic gonadotropin in gestational trophoblastic disease.
    Goldstein DP, Pastorfide GB, Osathanondh R, Kosasa TS.
    Obstet Gynecol; 1975 May; 45(5):527-30. PubMed ID: 164644
    [Abstract] [Full Text] [Related]

  • 12. Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
    Cole LA, Kohorn E, Smith HO.
    Obstet Gynecol Clin North Am; 2005 Dec; 32(4):615-26. PubMed ID: 16310675
    [Abstract] [Full Text] [Related]

  • 13. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results.
    Cole LA, Khanlian SA, Muller CY.
    J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919
    [Abstract] [Full Text] [Related]

  • 14. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA, Khanlian SA, Muller CY, Giddings A, Kohorn E, Berkowitz R.
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [Abstract] [Full Text] [Related]

  • 15. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [Abstract] [Full Text] [Related]

  • 16. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 17. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA, Sutton JM.
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [Abstract] [Full Text] [Related]

  • 18. Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.
    Cole LA, Muller CY.
    Gynecol Oncol; 2010 Jan; 116(1):3-9. PubMed ID: 19822356
    [Abstract] [Full Text] [Related]

  • 19. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E.
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [Abstract] [Full Text] [Related]

  • 20. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.